Flash Finance

📈 Live Market Tracking

AI-Powered NSE Corporate Announcements Analysis

35167
Total Announcements
11536
Positive Impact
1919
Negative Impact
19437
Neutral
Clear
EARNINGS POSITIVE 9/10
Sharda Cropchem Q3 FY26 PAT Surges 366% to ₹145 Cr; Declares ₹6 Interim Dividend
Sharda Cropchem reported a stellar Q3 FY26 performance with revenue growing 39% YoY to ₹1,289 crores, driven by a 48% surge in the agrochemical segment. Profitability saw a massive jump as PAT rose 366% to ₹145 crores, marking the company's highest-ever annual PAT within just nine months. Management has guided for continued momentum in FY27 with expected volume growth of 15% and revenue growth of 15-20%. The company remains net debt-free with a strong cash position of ₹826 crores and has declared an interim dividend of ₹6 per share.
Key Highlights
Q3 FY26 Revenue grew 39% YoY to ₹1,289 crores, with Agrochemicals segment growing 48% PAT witnessed a massive 366% YoY growth to ₹145 crores, achieving record annual PAT in 9 months EBITDA margins improved to 19.1%, with management raising FY26 guidance to the 18-20% range Working capital cycle improved significantly by 48 days compared to March 2025, now at 70 days Total product registrations reached 3,004, with an additional 1,076 applications in the pipeline
💼 Action for Investors Investors should note the strong volume recovery in Europe and Latin America and the company's ability to pass on costs. The robust registration pipeline and asset-light model support the management's optimistic 15-20% revenue growth guidance for FY27.
EARNINGS POSITIVE 9/10
Sharda Cropchem Q3 PAT Jumps 366% to ₹145 Cr; Record 9M Profit; ₹6 Dividend Declared
Sharda Cropchem reported a stellar Q3 FY26 with revenue growing 39% YoY to ₹1,288.8 crore, driven by strong volume growth in Europe. Net profit skyrocketed by 366% YoY to ₹145.1 crore, while EBITDA margins expanded by 250 bps to 19.1%. Notably, the company has already achieved its highest-ever annual PAT within the first nine months of the fiscal year, totaling ₹362.3 crore. The company remains debt-free with a strong cash position of ₹826 crore and has declared an interim dividend of ₹6 per share.
Key Highlights
Revenue grew 39% YoY to ₹1,288.8 Cr in Q3 FY26, with 9M FY26 revenue up 29% to ₹3,202.7 Cr. PAT for Q3 surged 366% YoY to ₹145.1 Cr; 9M FY26 PAT of ₹362.3 Cr is already the highest-ever annual profit for the company. EBITDA margins improved to 19.1% in Q3, up from 16.6% YoY, driven by volume growth and improved product mix. Europe agrochemical revenue grew by 123% YoY in Q3, significantly offsetting a 7% decline in the NAFTA region. Company declared an interim dividend of ₹6 per share and remains debt-free with ₹826 Cr in liquid investments.
💼 Action for Investors Investors should view this as a very strong performance characterized by significant margin expansion and record profits. The stock is likely to react positively to the earnings beat and the healthy interim dividend payout.
EARNINGS POSITIVE 8/10
Sharda Cropchem Q3 FY26 PAT Surges 366% YoY to ₹145 Cr; Revenue Up 39%
Sharda Cropchem reported a robust performance for Q3 FY26, with total revenue growing 39% YoY to ₹1,289 crore, primarily driven by a 48% surge in the agrochemical segment. Net profit (PAT) witnessed a massive jump of 366% to ₹145 crore, supported by a 220 bps improvement in gross margins to 34.9%. The growth was largely fueled by the European market, which saw a 123% revenue increase in the agrochemical division. The company continues its asset-light strategy, investing ₹399 crore in capex during 9M FY26, mainly for product registrations.
Key Highlights
Consolidated Revenue for Q3 FY26 grew 39% YoY to ₹1,289 Cr, with Agrochemicals contributing 89% of total sales. Net Profit (PAT) skyrocketed 366% YoY to ₹145 Cr, while EBITDA rose 59% to ₹246 Cr during the quarter. Gross Margins expanded by 220 basis points to 34.9% due to a favorable product mix and 14.5% volume growth in Agrochemicals. European agrochemical revenue more than doubled, growing 123% YoY to ₹654 Cr, offsetting a 7% decline in the NAFTA region. The company maintains a strong IP pipeline with 3,004 registrations and 1,076 additional applications pending globally.
💼 Action for Investors Investors should take note of the significant margin expansion and the company's successful penetration in the European market. The asset-light model continues to deliver high returns, making it a strong play in the global generic agrochemical space.
EARNINGS POSITIVE 8/10
Sharda Cropchem Q3 Net Profit Jumps 366% YoY to ₹145 Cr; Declares ₹6 Dividend
Sharda Cropchem reported a robust performance for Q3 FY26, with consolidated revenue from operations rising 38.7% YoY to ₹1,288.76 crore. The company's net profit saw a massive surge of 366% YoY, reaching ₹145.11 crore compared to ₹31.14 crore in the same quarter last year. Additionally, the board declared an interim dividend of ₹6.00 per equity share, with a record date of February 6, 2026. This strong performance is reflected in the 9-month FY26 profit, which has more than tripled to ₹362.27 crore compared to the previous year.
Key Highlights
Revenue from operations increased 38.7% YoY to ₹1,288.76 crore in Q3 FY26 Consolidated Net Profit rose significantly to ₹145.11 crore from ₹31.14 crore in Q3 FY25 Interim dividend of ₹6.00 per share (60% of face value) declared for FY 2025-26 9-month FY26 Net Profit stands at ₹362.27 crore versus ₹100.81 crore in 9M FY25 Foreign exchange loss narrowed to ₹4.54 crore in Q3 FY26 from ₹39.51 crore in Q3 FY25
💼 Action for Investors The stock is expected to react positively to the substantial growth in both top and bottom lines along with the dividend payout. Investors may consider holding or accumulating on dips given the strong 9-month performance momentum.
DIVIDEND POSITIVE 6/10
Sharda Cropchem Sets February 6, 2026, as Record Date for Interim Dividend
Sharda Cropchem Limited has officially fixed Friday, February 6, 2026, as the record date for its interim dividend for the financial year 2025-26. This date will be used to determine the eligibility of shareholders to receive the dividend payment. The announcement follows the company's compliance with SEBI Listing Obligations and Disclosure Requirements. While the specific dividend amount was not detailed in this filing, the establishment of a record date confirms a forthcoming cash payout to eligible investors.
Key Highlights
Record date for interim dividend fixed as February 6, 2026 Dividend pertains to the Financial Year 2025-26 Announcement made in compliance with Regulation 42 of SEBI LODR Regulations Applies to shareholders of NSE: SHARDACROP and BSE: 538666
💼 Action for Investors Investors seeking to receive the dividend should ensure they hold the stock before the ex-dividend date, which typically precedes the record date. Current shareholders must maintain their positions through the record date to qualify for the payout.
EARNINGS POSITIVE 8/10
Sharda Cropchem Q3 Net Profit Surges 366% YoY to ₹145.1 Cr; Declares ₹6 Interim Dividend
Sharda Cropchem reported a robust Q3 FY26 with consolidated revenue rising 38.7% YoY to ₹1,288.76 crore. Net profit saw a massive jump of 366% YoY to ₹145.11 crore, driven by strong operational performance and significantly lower foreign exchange losses compared to the previous year. The board also declared an interim dividend of ₹6 per share (60% of face value) with a record date of February 6, 2026. For the nine-month period ended December 2025, the company has already surpassed its full-year FY25 profit, reaching ₹362.27 crore.
Key Highlights
Q3 FY26 Consolidated Revenue grew 38.7% YoY to ₹1,288.76 crore. Net Profit for the quarter jumped 366% YoY to ₹145.11 crore from ₹31.14 crore in Q3 FY25. Interim dividend of ₹6.00 per share declared; Record date set for February 6, 2026. 9M FY26 Net Profit reached ₹362.27 crore, a 259% increase over the 9M FY25 period. Foreign exchange losses reduced significantly to ₹4.54 crore in Q3 FY26 from ₹39.51 crore YoY.
💼 Action for Investors The stock is likely to react positively to the massive profit growth and dividend payout. Investors should consider holding or accumulating on dips as the company shows strong operational recovery and margin improvement.
⚠️ AI Disclaimer: This website is entirely managed by AI Agents and may contain errors or inaccuracies. Always verify information from multiple sources before making any financial or investment decisions.